Frost JL, Schafer DP. Microglia: architects of the developing nervous system. Trends Cell Biol. 2016;26(8):587–97.
Article
PubMed
PubMed Central
Google Scholar
Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225–42.
Article
CAS
PubMed
Google Scholar
Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314–8.
Article
CAS
PubMed
Google Scholar
Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci. 2013;16(5):543–51.
Article
CAS
PubMed
Google Scholar
Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596–609.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cunningham CL, Martinez-Cerdeno V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33(10):4216–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 2009;27:119–45.
Article
CAS
PubMed
Google Scholar
Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):193–201.
Article
PubMed
Google Scholar
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405.
Article
CAS
PubMed
PubMed Central
Google Scholar
Crotti A, Glass CK. The choreography of neuroinflammation in Huntington’s disease. Trends Immunol. 2015;36(6):364–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med. 2008;205(8):1869–77.
Article
PubMed
PubMed Central
Google Scholar
McGeer PL, McGeer EG. Glial reactions in Parkinson’s disease. Mov Disord. 2008;23(4):474–83.
Article
PubMed
Google Scholar
More SV, Kumar H, Kim IS, Song SY, Choi DK. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease. Mediators Inflamm. 2013;2013:952375.
Article
PubMed
PubMed Central
Google Scholar
Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009;64(1):110–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463–77.
Article
CAS
PubMed
Google Scholar
Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777–83.
Article
CAS
PubMed
Google Scholar
Zhou JY, Oswald DM, Oliva KD, Kreisman LSC, Cobb BA. The glycoscience of immunity. Trends Immunol. 2018;39(7):523–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schnaar RL, Kinoshita T, et al. Glycosphingolipids. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, et al., editors. Essentials of glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2021.
Google Scholar
Copyright 2015–2017 by The Consortium of Glycobiology Editors, La Jolla, California. All rights reserved; 2015; p. 125–35.
Fukuda M, Rutishauser U, Schnaar RL. Neuroglycobiology. New York: Oxford University Press; 2005. p. 229.
Book
Google Scholar
Posse de Chaves E, Sipione S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 2010;584(9):1748–59.
Article
CAS
PubMed
Google Scholar
Sipione SMJ, Galleguillos D, Steinberg N, Kadam V. Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci. 2020;14:1–24.
Article
Google Scholar
Allende ML, Proia RL. Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function. Glycoconj J. 2014;31(9):613–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kracun I, Rosner H, Drnovsek V, Vukelic Z, Cosovic C, Trbojevic-Cepe M, et al. Gangliosides in the human brain development and aging. Neurochem Int. 1992;20(3):421–31.
Article
CAS
PubMed
Google Scholar
Mo L, Ren Q, Duchemin AM, Neff NH, Hadjiconstantinou M. GM1 and ERK signaling in the aged brain. Brain Res. 2005;1054(2):125–34.
Article
CAS
PubMed
Google Scholar
Palestini P, Masserini M, Sonnino S, Giuliani A, Tettamanti G. Changes in the ceramide composition of rat forebrain gangliosides with age. J Neurochem. 1990;54(1):230–5.
Article
CAS
PubMed
Google Scholar
Segler-Stahl K, Webster JC, Brunngraber EG. Changes in the concentration and composition of human brain gangliosides with aging. Gerontology. 1983;29(3):161–8.
Article
CAS
PubMed
Google Scholar
Maglione V, Marchi P, Di Pardo A, Lingrell S, Horkey M, Tidmarsh E, et al. Impaired ganglioside metabolism in Huntington’s disease and neuroprotective role of GM1. J Neurosci. 2010;30(11):4072–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Desplats PA, Denny CA, Kass KE, Gilmartin T, Head SR, Sutcliffe JG, et al. Glycolipid and ganglioside metabolism imbalances in Huntington’s disease. Neurobiol Dis. 2007;27(3):265–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu G, Lu ZH, Kulkarni N, Ledeen RW. Deficiency of ganglioside GM1 correlates with Parkinson’s disease in mice and humans. J Neurosci Res. 2012;90(10):1997–2008.
Article
CAS
PubMed
Google Scholar
Schneider JS. Altered expression of genes involved in ganglioside biosynthesis in substantia Nigra neurons in Parkinson’s disease. PLoS ONE. 2018;13(6):e0199189.
Article
PubMed
PubMed Central
Google Scholar
Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, et al. Gangliosides in cerebrospinal fluid in ‘probable Alzheimer’s disease.’ Arch Neurol. 1991;48(10):1032–5.
Article
CAS
PubMed
Google Scholar
Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Mansson JE, et al. Differences in cerebrospinal fluid gangliosides between “probable Alzheimer’s disease” and normal aging. Aging (Milano). 1992;4(4):301–6.
CAS
Google Scholar
Alpaugh M GD, Forero J, Morales LC, Lackey S, Kar P, Di Pardo A, Holt A, Kerr B, Todd K, Baker GB, Fouad K, Sipione S. Therapeutic and disease-modifying effects of ganglioside GM1 in mouse models of Huntington’s disease. Submitted2017.
Magistretti PJ, Geisler FH, Schneider JS, Li PA, Fiumelli H, Sipione S. Gangliosides: treatment avenues in neurodegenerative disease. Front Neurol. 2019;10:859.
Article
PubMed
PubMed Central
Google Scholar
Pope-Coleman A, Schneider JS. Effects of chronic GM1 ganglioside treatment on cognitieve and motor deficits in a slowly progressing model of parkinsonism in non-human primates. Restor Neurol Neurosci. 1998;12(4):255–66.
CAS
PubMed
Google Scholar
Schneider JS. GM1 ganglioside in the treatment of Parkinson’s disease. Ann N Y Acad Sci. 1998;845:363–73.
Article
CAS
PubMed
Google Scholar
Schneider JS, Aras R, Williams CK, Koprich JB, Brotchie JM, Singh V. GM1 ganglioside modifies alpha-synuclein toxicity and is neuroprotective in a rat alpha-synuclein model of Parkinson’s disease. Sci Rep. 2019;9(1):8362.
Article
PubMed
PubMed Central
Google Scholar
Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P, et al. Disease-modifying effects of ganglioside GM1 in Huntington’s disease models. EMBO Mol Med. 2017;9(11):1537–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Di Pardo A, Maglione V, Alpaugh M, Horkey M, Atwal RS, Sassone J, et al. Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc Natl Acad Sci U S A. 2012;109(9):3528–33.
Article
PubMed
PubMed Central
Google Scholar
Ohmi Y, Tajima O, Ohkawa Y, Yamauchi Y, Sugiura Y, Furukawa K, et al. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J Neurochem. 2011;116(5):926–35.
Article
CAS
PubMed
Google Scholar
Ohmi Y, Ohkawa Y, Tajima O, Sugiura Y, Furukawa K, Furukawa K. Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord. J Neuroinflammation. 2014;11:61.
Article
PubMed
PubMed Central
Google Scholar
Gong G, Yin L, Yuan L, Sui D, Sun Y, Fu H, et al. Ganglioside GM1 protects against high altitude cerebral edema in rats by suppressing the oxidative stress and inflammatory response via the PI3K/AKT-Nrf2 pathway. Mol Immunol. 2018;95:91–8.
Article
CAS
PubMed
Google Scholar
Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia. 2003;44(3):183–9.
Article
PubMed
Google Scholar
Walsh JG, Reinke SN, Mamik MK, McKenzie BA, Maingat F, Branton WG, et al. Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS. Retrovirology. 2014;11:35.
Article
PubMed
PubMed Central
Google Scholar
Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol. 1990;27(2–3):229–37.
Article
CAS
PubMed
Google Scholar
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.
Henn A, Lund S, Hedtjärn M, Schrattenholz A, Pörzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex. 2009;26(2):83–94.
Article
PubMed
Google Scholar
Franklin TC, Xu C, Duman RS. Depression and sterile inflammation: essential role of danger associated molecular patterns. Brain Behav Immun. 2018;72:2–13.
Article
CAS
PubMed
Google Scholar
Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006;290(3):C917–24.
Article
CAS
PubMed
Google Scholar
Azam S, Jakaria M, Kim IS, Kim J, Haque ME, Choi DK. Regulation of toll-like receptor (TLR) signaling pathway by polyphenols in the treatment of age-linked neurodegenerative diseases: focus on TLR4 signaling. Front Immunol. 2019;10:1000.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rauvala H. Monomer-micelle transition of the ganglioside GM1 and the hydrolysis by clostridium perfringens neuraminidase. Eur J Biochem. 1979;97(2):555–64.
Article
CAS
PubMed
Google Scholar
Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016;113(12):E1738–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hovens IB, Nyakas C, Schoemaker RG. A novel method for evaluating microglial activation using ionized calcium-binding adaptor protein-1 staining: cell body to cell size ratio. Neuroimmunol Neuroinflammation. 2014;1:82–8.
Article
Google Scholar
García-Magro N, Martin YB, Palomino-Antolin A, Egea J, Negredo P, Avendaño C. Multiple morphometric assessment of microglial cells in deafferented spinal trigeminal nucleus. Front Neuroanat. 2019;13:103.
Article
PubMed
Google Scholar
Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol. 2009;40(2):139–56.
Article
CAS
PubMed
Google Scholar
Taylor AMW, Mehrabani S, Liu S, Taylor AJ, Cahill CM. Topography of microglial activation in sensory- and affect-related brain regions in chronic pain. J Neurosci Res. 2017;95(6):1330–5.
Article
CAS
PubMed
Google Scholar
Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11(6).
Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikainen S, Kovanen PT, et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE. 2010;5(7):e11765.
Article
PubMed
PubMed Central
Google Scholar
Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakatsuki S, Nishijima M, et al. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A. 2008;105(2):488–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fantini J, Barrantes FJ. Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta. 2009;1788(11):2345–61.
Article
CAS
PubMed
Google Scholar
Inokuchi J, Usuki S, Jimbo M. Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells. J Biochem. 1995;117(4):766–73.
Article
CAS
PubMed
Google Scholar
Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet. 2004;36(11):1225–9.
Article
CAS
PubMed
Google Scholar
Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, et al. Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur J Hum Genet. 2013;21(5):528–34.
Article
CAS
PubMed
Google Scholar
Boccuto L, Aoki K, Flanagan-Steet H, Chen CF, Fan X, Bartel F, et al. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet. 2014;23(2):418–33.
Article
CAS
PubMed
Google Scholar
Wakil SM, Monies DM, Ramzan K, Hagos S, Bastaki L, Meyer BF, et al. Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia. Clin Genet. 2014;86(5):500–1.
Article
CAS
PubMed
Google Scholar
Harlalka GV, Lehman A, Chioza B, Baple EL, Maroofian R, Cross H, et al. Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain. 2013;136(Pt 12):3618–24.
Article
PubMed
PubMed Central
Google Scholar
Boukhris A, Schule R, Loureiro JL, Lourenco CM, Mundwiller E, Gonzalez MA, et al. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Genet. 2013;93(1):118–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shayman JA. The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity? Trans Am Clin Climatol Assoc. 2013;124:46–60.
PubMed
PubMed Central
Google Scholar
Oppenheimer S. GM1 ganglioside therapy in acute ischemic stroke. Stroke. 1990;21(5):825.
Article
CAS
PubMed
Google Scholar
Simon RP, Chen J, Graham SH. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study. J Pharmacol Exp Ther. 1993;265(1):24–9.
CAS
PubMed
Google Scholar
Pope-Coleman A, Tinker JP, Schneider JS. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys. Synapse. 2000;36(2):120–8.
Article
CAS
PubMed
Google Scholar
Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du W. A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson’s disease patients. J Neurol Sci. 2013;324(1–2):140–8.
Article
CAS
PubMed
Google Scholar
Ledeen RW, Wu G. Gangliosides, alpha-Synuclein, and Parkinson’s disease. Prog Mol Biol Transl Sci. 2018;156:435–54.
Article
CAS
PubMed
Google Scholar
Ledeen RW, Wu G. The multi-tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem Sci. 2015;40(7):407–18.
Article
CAS
PubMed
Google Scholar
Mocchetti I. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol Life Sci. 2005;62(19–20):2283–94.
Article
CAS
PubMed
Google Scholar
Kwan W, Trager U, Davalos D, Chou A, Bouchard J, Andre R, et al. Mutant huntingtin impairs immune cell migration in Huntington disease. J Clin Invest. 2012;122(12):4737–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17(4):513–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moller T. Neuroinflammation in Huntington’s disease. J Neural Transm. 2010;117(8):1001–8.
Article
PubMed
Google Scholar
Park JY, Kim HY, Jou I, Park SM. GM1 induces p38 and microtubule dependent ramification of rat primary microglia in vitro. Brain Res. 2008;1244:13–23.
Article
CAS
PubMed
Google Scholar
Min KJ, Pyo HK, Yang MS, Ji KA, Jou I, Joe EH. Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia. 2004;48(3):197–206.
Article
PubMed
Google Scholar
Min KJ, Yang MS, Jou I, Joe EH. Protein kinase A mediates microglial activation induced by plasminogen and gangliosides. Exp Mol Med. 2004;36(5):461–7.
Article
CAS
PubMed
Google Scholar
Pyo H, Joe E, Jung S, Lee SH, Jou I. Gangliosides activate cultured rat brain microglia. J Biol Chem. 1999;274(49):34584–9.
Article
CAS
PubMed
Google Scholar
Ziegler-Heitbrock HW, Kafferlein E, Haas JG, Meyer N, Strobel M, Weber C, et al. Gangliosides suppress tumor necrosis factor production in human monocytes. J Immunol. 1992;148(6):1753–8.
CAS
PubMed
Google Scholar
Wang Y, Cui Y, Cao F, Qin Y, Li W, Zhang J. Ganglioside GD1a suppresses LPS-induced pro-inflammatory cytokines in RAW264.7 macrophages by reducing MAPKs and NF-kappaB signaling pathways through TLR4. Int Immunopharmacol. 2015;28(1):136–45.
Article
PubMed
Google Scholar
Shen W, Stone K, Jales A, Leitenberg D, Ladisch S. Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides. J Immunol. 2008;180(7):4425–32.
Article
CAS
PubMed
Google Scholar
Ariga T, Yu RK. GM1 inhibits amyloid beta-protein-induced cytokine release. Neurochem Res. 1999;24(2):219–26.
Article
CAS
PubMed
Google Scholar
Ariga T, Kiso M, Hasegawa A, Miyatake T. Gangliosides inhibit the release of interleukin-1beta in amyloid beta-protein-treated human monocytic cells. J Mol Neurosci. 2001;17(3):371–7.
Article
CAS
PubMed
Google Scholar
Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong J-S, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453–62.
Article
PubMed
PubMed Central
Google Scholar
Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y. Macrophage/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma -dependent pathway. J Biol Chem. 2002;277(22):20026–32.
Article
CAS
PubMed
Google Scholar
Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci. 2000;113(Pt 17):3073–84.
Article
CAS
PubMed
Google Scholar
Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994;180(2):147–50.
Article
CAS
PubMed
Google Scholar
Hull M, Berger M, Volk B, Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheimer’s disease patients may precede transformation of diffuse into neuritic plaques. Ann N Y Acad Sci. 1996;777:205–12.
Article
CAS
PubMed
Google Scholar
Rothaug M, Becker-Pauly C, Rose-John S. The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta. 2016;1863(6 Pt A):1218–27.
Article
CAS
PubMed
Google Scholar
Wagner JA. Is IL-6 both a cytokine and a neurotrophic factor? J Exp Med. 1996;183(6):2417–9.
Article
CAS
PubMed
Google Scholar
Akaneya Y, Takahashi M, Hatanaka H. Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol. 1995;136(1):44–52.
Article
CAS
PubMed
Google Scholar
Hirota H, Kiyama H, Kishimoto T, Taga T. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med. 1996;183(6):2627–34.
Article
CAS
PubMed
Google Scholar
Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science. 1997;278(5337):477–83.
Article
CAS
PubMed
Google Scholar
Chucair-Elliott AJ, Conrady C, Zheng M, Kroll CM, Lane TE, Carr DJ. Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia. 2014;62(9):1418–34.
Article
PubMed
PubMed Central
Google Scholar
Cavaillon JM, Fitting C, Hauttecoeur B, Haeffner-Cavaillon N. Inhibition by gangliosides of the specific binding of lipopolysaccharide (LPS) to human monocytes prevents LPS-induced interleukin-1 production. Cell Immunol. 1987;106(2):293–303.
Article
CAS
PubMed
Google Scholar
Jeng KC, Chen TL, Lan JL. Gangliosides suppression of murine lymphoproliferation and interleukin 1 production. Immunol Lett. 1988;19(4):335–40.
Article
CAS
PubMed
Google Scholar
Jou I, Lee JH, Park SY, Yoon HJ, Joe EH, Park EJ. Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol. 2006;168(5):1619–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boyd CR, Orr SJ, Spence S, Burrows JF, Elliott J, Carroll HP, et al. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J Immunol. 2009;183(12):7703–9.
Article
CAS
PubMed
Google Scholar
Macauley MS, Crocker PR, Paulson JC. Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol. 2014;14(10):653–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen G-Y, Brown NK, Wu W, Khedri Z, Yu H, Chen X, et al. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. eLife. 2014;3.
Chiricozzi E, Pomè DY, Maggioni M, Di Biase E, Parravicini C, Palazzolo L, et al. Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells. J Neurochem. 2017;143(6):645–59.
Article
CAS
PubMed
Google Scholar
Sonnino S, Mauri L, Chigorno V, Prinetti A. Gangliosides as components of lipid membrane domains. Glycobiology. 2007;17(1):1R-13R.
Article
CAS
PubMed
Google Scholar
van der Bruggen T, Nijenhuis S, van Raaij E, Verhoef J, van Asbeck BS. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun. 1999;67(8):3824–9.
Article
PubMed
PubMed Central
Google Scholar
Gais P, Tiedje C, Altmayr F, Gaestel M, Weighardt H, Holzmann B. TRIF signaling stimulates translation of TNF-α mRNA via prolonged activation of MK2. J Immunol. 2010;184(10):5842–8.
Article
CAS
PubMed
Google Scholar
Mazumder B, Li X, Barik S. Translation control: a multifaceted regulator of inflammatory response. J Immunol. 2010;184(7):3311–9.
Article
CAS
PubMed
Google Scholar